GLP-1 drugs reshape alcohol consumption and hospitality habits
Why does this matter?
GLP-1 drugs are driving measurable declines in alcohol consumption (23-39% of users) and creating demand for low/no-alcohol options, smaller portions, and transparency—presenting significant product innovation and market opportunities for BevTech founders.
Highlights
Millions of Britons using GLP-1 weight loss medications are beginning to alter